| Market Cap | ₹37Cr |
| ROE | 9.90% |
| P/E Ratio(TTM) | 11.85 |
| EPS(TTM) | 1.76 |
| P/B Ratio | 1.18 |
| Dividend Yield | 0.00% |
| Industry P/E | 35.13 |
| Book Value | 17.66 |
| Debt to Equity | 1.72 |
| Face Value | 10 |
| Parent Organisation | Mono Pharmacare |
| Managing Director | Mr. Panilam Lakhatariya |
| NSE Symbol | MONOPHARMA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 102.01 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.92 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.42 | ||
| Wockhardt | NA (0.00%) | -145.08 |